                         SEQUENCE LISTING

<110>  University of Kentucky Research Foundation
 
<120>  METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE

<130>  13177N/2025US

<150>  US 62/908,937
<151>  2019-10-01

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  16S rRNA forward

<400>  1
tcccaatggt gcagaagcta tta                                               23


<210>  2
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  16S rRNA reverse

<400>  2
aaggaggctc catttctctt gtc                                               23


<210>  3
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Beta Actin forward

<400>  3
ctaaaggtga ccaatgctgg agg                                               23


<210>  4
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Beta Actin reverse

<400>  4
tggcatagag gtctttacgg atg                                               23


<210>  5
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miR-103-3p

<400>  5
agcagcauug uacagggcua uga                                               23


<210>  6
<211>  24
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miR-107-3p

<400>  6
agcuucuuua caguguugcc uugu                                              24


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LRP1 forward primer

<400>  7
ttgtgctgag ccaagacatc                                                   20


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LRP1 reverse primer

<400>  8
ggcgtggaag acatgtaggt                                                   20


<210>  9
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAPDH forward primer

<400>  9
gctgcgtttt acaccctttc                                                   20


<210>  10
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAPDH reverse primer

<400>  10
gtttgctcca accaactgc                                                    19


